Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can certain fats reduce lipitor's efficacy?How do antacids impact tigecycline's effectiveness?How does ruxolitinib's response compare with azacitidine alone?Entresto patent expiration date?How does lipitor's competition impact prescription costs?
See the DrugPatentWatch profile for tigecycline
Tigecycline is designed to target a range of bacteria, with particular focus on multi-drug resistant organisms. The bacteria it is primarily used against include: - Methicillin-resistant Staphylococcus aureus (MRSA) - Vancomycin-resistant Enterococcus (VRE) - Resistant Streptococcus species (including some cases involving resistance patterns seen in clinical settings) - Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria - Carbapenem-resistant Gram-negative bacteria Tigecycline’s spectrum also includes other common hospital-associated infections caused by susceptible Gram-positive and Gram-negative bacteria, but it is most noted for activity against resistant strains listed above.
Other Questions About Tigecycline :